These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 23056401)
1. The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer. Takahashi M; Cuatrecasas M; Balaguer F; Hur K; Toiyama Y; Castells A; Boland CR; Goel A PLoS One; 2012; 7(10):e46684. PubMed ID: 23056401 [TBL] [Abstract][Full Text] [Related]
2. Significance of miR-148a in Colorectal Neoplasia: Downregulation of miR-148a Contributes to the Carcinogenesis and Cell Invasion of Colorectal Cancer. Hibino Y; Sakamoto N; Naito Y; Goto K; Oo HZ; Sentani K; Hinoi T; Ohdan H; Oue N; Yasui W Pathobiology; 2015; 82(5):233-41. PubMed ID: 26389729 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of microRNA-148a in patients with early relapse of stage II stage and III colorectal cancer after curative resection. Tsai HL; Yang IP; Huang CW; Ma CJ; Kuo CH; Lu CY; Juo SH; Wang JY Transl Res; 2013 Oct; 162(4):258-68. PubMed ID: 23933284 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding. Baltruskeviciene E; Schveigert D; Stankevicius V; Mickys U; Zvirblis T; Bublevic J; Suziedelis K; Aleknavicius E BMC Cancer; 2017 Sep; 17(1):607. PubMed ID: 28863773 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer. Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755 [TBL] [Abstract][Full Text] [Related]
6. High expression of miR-181c as a predictive marker of recurrence in stage II colorectal cancer. Yamazaki N; Koga Y; Taniguchi H; Kojima M; Kanemitsu Y; Saito N; Matsumura Y Oncotarget; 2017 Jan; 8(4):6970-6983. PubMed ID: 28036302 [TBL] [Abstract][Full Text] [Related]
7. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer. Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y Oncology; 2017; 92(6):360-370. PubMed ID: 28376502 [TBL] [Abstract][Full Text] [Related]
8. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer. Zou G; Wang R; Wang M Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664 [TBL] [Abstract][Full Text] [Related]
9. MiR-320e is a novel prognostic biomarker in colorectal cancer. Perez-Carbonell L; Sinicrope FA; Alberts SR; Oberg AL; Balaguer F; Castells A; Boland CR; Goel A Br J Cancer; 2015 Jun; 113(1):83-90. PubMed ID: 26035698 [TBL] [Abstract][Full Text] [Related]
10. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer. Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793 [TBL] [Abstract][Full Text] [Related]
11. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer. Yuan D; Li K; Zhu K; Yan R; Dang C Cancer Biol Ther; 2015; 16(2):268-75. PubMed ID: 25629978 [TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer. Qiu X; Zhu H; Liu S; Tao G; Jin J; Chu H; Wang M; Tong N; Gong W; Zhao Q; Qiang F; Zhang Z J Gastroenterol Hepatol; 2017 Apr; 32(4):819-827. PubMed ID: 27529338 [TBL] [Abstract][Full Text] [Related]
13. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer. Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702 [TBL] [Abstract][Full Text] [Related]
14. Altered miR-21, miRNA-148a Expression in Relation to KRAS Mutation Status as Indicator of Adenoma-Carcinoma Transitional Pattern in Colorectal Adenoma and Carcinoma Lesions. Igder S; Mohammadiasl J; Mokarram P Biochem Genet; 2019 Dec; 57(6):767-780. PubMed ID: 30997628 [TBL] [Abstract][Full Text] [Related]
15. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma. Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727 [TBL] [Abstract][Full Text] [Related]
16. Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer. Kandimalla R; Gao F; Matsuyama T; Ishikawa T; Uetake H; Takahashi N; Yamada Y; Becerra C; Kopetz S; Wang X; Goel A Clin Cancer Res; 2018 Aug; 24(16):3867-3877. PubMed ID: 29514841 [No Abstract] [Full Text] [Related]
17. High microRNA-28-5p expression in colorectal adenocarcinoma predicts short-term relapse of node-negative patients and poor overall survival of patients with non-metastatic disease. Tsiakanikas P; Kontos CK; Kerimis D; Papadopoulos IN; Scorilas A Clin Chem Lab Med; 2018 May; 56(6):990-1000. PubMed ID: 29688883 [TBL] [Abstract][Full Text] [Related]
18. Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma. Li J; Liu Y; Wang C; Deng T; Liang H; Wang Y; Huang D; Fan Q; Wang X; Ning T; Liu R; Zhang CY; Zen K; Chen X; Ba Y Sci Rep; 2015 Aug; 5():12921. PubMed ID: 26250939 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study. Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286 [TBL] [Abstract][Full Text] [Related]
20. Examining plasma microRNA markers for colorectal cancer at different stages. Sun Y; Liu Y; Cogdell D; Calin GA; Sun B; Kopetz S; Hamilton SR; Zhang W Oncotarget; 2016 Mar; 7(10):11434-49. PubMed ID: 26863633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]